Bio Plus Co., Ltd (KOSDAQ:099430)

South Korea · Delayed Price · Currency is KRW

5,260.00

+110.00 (2.14%)

Apr 10, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals			65.04B	56.72B	37.42B	24.37B	17.02B
Pharmaceuticals Growth			14.68%	51.58%	53.56%	43.16%	54.20%
Total			65.04B	56.72B	37.42B	24.37B	17.02B
Total Growth			14.68%	51.58%	53.56%	43.16%	54.20%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Export			-	-	-	-	11.84B
Export Growth			-	-	-	-	19.23%
South Korea			-	-	-	-	5.18B
South Korea Growth			-	-	-	-	368.36%
Total			-	-	-	-	17.02B
Total Growth			-	-	-	-	54.20%

Source: S&P Global Market Intelligence.